These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 22842290)

  • 21. Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison.
    Lamont L; Hadavi D; Viehmann B; Flinders B; Heeren RMA; Vreeken RJ; Porta Siegel T
    Anal Bioanal Chem; 2021 Apr; 413(10):2779-2791. PubMed ID: 33770207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Qualitative and quantitative mass spectrometry imaging of drugs and metabolites in tissue at therapeutic levels.
    Sun N; Walch A
    Histochem Cell Biol; 2013 Aug; 140(2):93-104. PubMed ID: 23881163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of MALDI-MSI to pharmaceutical research.
    Prideaux B; Staab D; Stoeckli M
    Methods Mol Biol; 2010; 656():405-13. PubMed ID: 20680604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping pharmaceuticals in tissues using MALDI imaging mass spectrometry.
    Hsieh Y; Chen J; Korfmacher WA
    J Pharmacol Toxicol Methods; 2007; 55(2):193-200. PubMed ID: 16919485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of MALDI mass spectrometry imaging for pharmacokinetic studies during drug development.
    Nishidate M; Hayashi M; Aikawa H; Tanaka K; Nakada N; Miura SI; Ryu S; Higashi T; Ikarashi Y; Fujiwara Y; Hamada A
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):209-216. PubMed ID: 31101590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging mass spectrometry in drug development and toxicology.
    Karlsson O; Hanrieder J
    Arch Toxicol; 2017 Jun; 91(6):2283-2294. PubMed ID: 27933369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MALDI mass spectrometry imaging, from its origins up to today: the state of the art.
    Francese S; Dani FR; Traldi P; Mastrobuoni G; Pieraccini G; Moneti G
    Comb Chem High Throughput Screen; 2009 Feb; 12(2):156-74. PubMed ID: 19199884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoradiography, MALDI-MS, and SIMS-MS imaging in pharmaceutical discovery and development.
    Solon EG; Schweitzer A; Stoeckli M; Prideaux B
    AAPS J; 2010 Mar; 12(1):11-26. PubMed ID: 19921438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput liquid chromatography/mass spectrometry method for the quantitation of small molecules using accurate mass technologies in supporting discovery drug screening.
    Ding X; Ghobarah H; Zhang X; Jaochico A; Liu X; Deshmukh G; Liederer BM; Hop CE; Dean B
    Rapid Commun Mass Spectrom; 2013 Feb; 27(3):401-8. PubMed ID: 23280971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future technology insight: mass spectrometry imaging as a tool in drug research and development.
    Cobice DF; Goodwin RJ; Andren PE; Nilsson A; Mackay CL; Andrew R
    Br J Pharmacol; 2015 Jul; 172(13):3266-83. PubMed ID: 25766375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An introduction to MS imaging in drug discovery and development.
    Lodén H; Shariatgorji M; Nilsson A; Andrén PE
    Bioanalysis; 2015; 7(20):2621-7. PubMed ID: 26511071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technologies and strategies to characterize and quantitate metabolites in drug discovery and development.
    Ravindran S; Jadhav A; Surve P; Lonsane G; Honrao P; Nanda B
    Biomed Chromatogr; 2014 Nov; 28(11):1547-53. PubMed ID: 25175001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative Mass Spectrometry Imaging of Biological Systems.
    Unsihuay D; Mesa Sanchez D; Laskin J
    Annu Rev Phys Chem; 2021 Apr; 72():307-329. PubMed ID: 33441032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementarity of molecular and elemental mass spectrometric imaging of Gadovist
    Trog S; El-Khatib AH; Beck S; Makowski MR; Jakubowski N; Linscheid MW
    Anal Bioanal Chem; 2019 Jan; 411(3):629-637. PubMed ID: 30456604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of drug distribution by ambient mass spectrometry imaging method with signal extinction normalization strategy and inkjet-printing technology.
    Luo Z; He J; He J; Huang L; Song X; Li X; Abliz Z
    Talanta; 2018 Mar; 179():230-237. PubMed ID: 29310227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of imaging mass spectrometry approaches to facilitate metal-based anticancer drug research.
    Lee RFS; Theiner S; Meibom A; Koellensperger G; Keppler BK; Dyson PJ
    Metallomics; 2017 Apr; 9(4):365-381. PubMed ID: 28154861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatial Quantitation of Drugs in tissues using Liquid Extraction Surface Analysis Mass Spectrometry Imaging.
    Swales JG; Strittmatter N; Tucker JW; Clench MR; Webborn PJH; Goodwin RJA
    Sci Rep; 2016 Nov; 6():37648. PubMed ID: 27883030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatial analysis of drug absorption, distribution, metabolism, and toxicology using mass spectrometry imaging.
    Spruill ML; Maletic-Savatic M; Martin H; Li F; Liu X
    Biochem Pharmacol; 2022 Jul; 201():115080. PubMed ID: 35561842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of mass spectrometry imaging in virus research.
    Bertzbach LD; Kaufer BB; Karger A
    Adv Virus Res; 2021; 109():31-62. PubMed ID: 33934829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.